Abstract
Introduction. The postpartum period is considered a period of increased risk of developing bipolar affective disorder (BDII) type II. According to the available data, postpartum BDII is a highly neglected area of observation, with negative consequences for mothers, offspring, and the family as a whole. Case report. The paper describes the case of a patient with symptoms of a depressive episode of atypical features following childbirth. The patient had one mild postpartum depression episode and multiple previously detected hypomania-like episodes. Postpartum depression and bipolar affective disorder were detected in the family history. Escitalopram 20 mg in combination with Lamotrigine 200 mg was prescribed. There were no detected side effects to the prescribed therapeutic dose, and there have been no relapses so far. Conclusion. During pregnancy and postpartum, women should be screened for BDII. Based on the experience from the presented case, the combination of escitalopram and lamotrigine has shown promising results and complies with all recommended BDII treatment guidelines.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference12 articles.
1. American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing Text Citation: (American Psychiatric Association, 2013 https://doi.org/10.1176/appi.books.9780890425596;
2. Merikangas KR, Akiskal HS, Angst J et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2007; 64:543-52;
3. Stahl SM. Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4 th ed.). Cambridge University Press. 2016;
4. WHO. International Statistical Classification of Diseases and Related Health Problems, 11 th Revision: ICD-11. World Health Organization, Geneva, June 2018. https://doi.org/10.1071/SH17086;
5. Stojanov J, Stankovic M, Zikic O, Stankovic M, Stojanov A. The risk for nonpsychotic postpartum mood and anxiety disorders during the COVID-19 pandemic. Int J Psychiatry Med 2021;56(4):228-39. https://doi.org/10.1177/0091217420981533;